ZERO Prostate Cancer Announces Major Veterans Action Event for 2026

ZERO Prostate Cancer Announces 2026 Veterans Action Convening

In a significant move to enhance the lives of veterans affected by prostate cancer, ZERO Prostate Cancer has unveiled the upcoming 2026 Veterans' Action Convening. Scheduled for January 27-28, 2026, in Arlington, Virginia, this pivotal gathering aims to engage veteran survivors, healthcare professionals, and community advocates.

Prostate cancer has been identified as a major health concern among veterans, who often face heightened risks and unique challenges when seeking diagnosis and treatment. With too many veterans encountering delays, confusion, and accessibility issues in their healthcare journey, the Veterans' Action Convening seeks to address these barriers through robust discussion and collaboration.

Paul Caseley, Veterans Program Manager at ZERO Prostate Cancer, emphasized the urgent need for improved access to healthcare for veterans. He stated, “Veterans have earned access to the highest standard of cancer care, yet too many face delays, gaps, or confusion when navigating prostate cancer screening and treatment.” This event embodies a commitment to listening to veterans’ experiences and fostering dialogues that translate into actionable results.

During the two-day event, participants will engage with findings from a national survey focusing on veterans' experiences with prostate cancer screening, treatment, and survivorship. These insights will help shape a coalition aimed at developing strategic approaches to enhance care and support for veterans going forward. This coalition will also influence ZERO’s initiatives throughout 2026 and beyond, ensuring that the voices of veterans are at the forefront of advocacy efforts.

The significance of the 2026 Veterans' Action Convening cannot be overstated. It represents a dedicated effort to improve the quality of life for veterans and their families who are dealing with the impact of prostate cancer. By uniting various stakeholders—including veterans, advocacy groups, and medical professionals—the event aims to foster a comprehensive national response tailored to the unique needs of veterans and their healthcare challenges.

Furthermore, ZERO Prostate Cancer, founded in 1996, has been at the forefront of advocacy and support for individuals affected by prostate cancer. The organization aims to ensure early detection, sustained support, and accessible care for everyone impacted by this disease. As the leading prostate cancer organization in the nation, ZERO has helped millions navigate their journeys through education and resource provision, highlighting critical needs in diagnosis and treatment.

For nearly three decades, ZERO has unlocked substantial funding towards research and innovative treatments, delivering lifesaving access to care. The organization’s proactive approach emphasizes breaking down barriers to survival, firmly focusing on those most susceptible to prostate cancer.

The 2026 Veterans' Action Convening is more than just an event; it is a call to action for everyone involved in prostate cancer care for veterans. With a strong emphasis on collaboration, the gathering aims to pave the way for future advancements in healthcare tailored specifically for veterans, enhancing both their treatment outcomes and overall quality of life. Interested parties are encouraged to participate in this collaborative effort, which is poised to make a profound impact during the event and beyond.

To learn more about ZERO Prostate Cancer and their initiatives, visit ZEROcancer.org.